Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment

Merck & Co.’s immunotherapy cancer drug Keytruda received U.S. Food and Drug Administration approval as a first-line treatment for certain lung cancer patients.

from WSJ.com: US Business http://ift.tt/2eMwv1M
via IFTTT